NCT06307262

European Registry of Transcatheter Repair for Tricuspid Regurgitation

European Registry of Transcatheter Repair for Tricuspid Regurgitation (EuroTR)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 3,000 (estimated)
• Sponsor: LMU Klinikum · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To investigate clinical and survival outcomes following transcatheter tricuspid valve repair or replacement.

Detailed description

Background and Rationale: Tricuspid regurgitation (TR) is a major health and economic burden due to high rates of heart failure hospitalizations, morbidity and mortality. Surcial treatment of TR is associated with high procedural and in-hospital mortality. Due to prohibitive surgical risk, a significant proportion of patients historically remained untreted beyond medical therapy. Transcatheter tricuspid valve (TV) repair and replacement techniques (TTVT) now offer a new treatment perspective for these patients. The EuroTR registry aims at optimizing patient selection prior to TTVT and thus treatment quality by collecting respective data in a real-world setting. Objectives: To investigate clinical and survival outcome following transcatheter tricuspid valve repair or replacement.

Conditions

• Tricuspid Regurgitation
• Valvular Heart Disease
• Heart Failure

Interventions

Type	Name	Description
DEVICE	T-TEER	T-TEER using the PACAL or TriClip device

Timeline

• Start date: 2023-10-23
• Primary completion: 2030-12-31
• Completion: 2030-12-31
• First posted: 2024-03-12
• Last updated: 2024-03-15

Locations

1 site across 1 country: Germany